Lowest combined ratio in 14 quarters, driven by better expense ratios and reinsurance terms.
Bajajfinsv Ltd — Q2 FY24
Bajaj Finserv delivered a strong Q2 FY24 with consolidated revenue up 25% YoY to INR 26,023 crore and PAT up 24% YoY to INR 1,929 crore.
✓ Verified against BSE filing
2-Minute Summary
Bajaj Finserv delivered a strong Q2 FY24 with consolidated revenue up 25% YoY to INR 26,023 crore and PAT up 24% YoY to INR 1,929 crore. Growth was driven by robust performance across subsidiaries: BAGIC reported a 95.3% combined ratio (lowest in 14 quarters) and 39% PAT growth, while BALIC saw NBV growth of 25% to INR 237 crore. BFL continued its momentum with 33% AUM growth and asset quality improvement. The AMC business launched with INR 5,235 crore AUM. Management guided for continued balanced growth, with BAGIC targeting sub-100% combined ratio despite near-term investment costs. Key risk: elevated claims volatility in government health and crop insurance segments could pressure underwriting profitability.
बजाज फिनसर्व ने दूसरी तिमाही में शानदार प्रदर्शन किया। कंपनी की कुल कमाई पिछले साल से 25% बढ़कर 26,023 करोड़ रुपये हो गई। मुनाफा भी 24% बढ़कर 1,929 करोड़ रुपये पहुंच गया। इसकी मुख्य कंपनियों ने अच्छा काम किया। बीमा कंपनी BAGIC का खर्च-आय अनुपात 95.3% रहा, जो 14 तिमाहियों में सबसे कम है। दूसरी बीमा कंपनी BALIC का नया कारोबार मूल्य 25% बढ़कर 237 करोड़ रुपये हुआ। फाइनेंस कंपनी BFL की संपत्ति 33% बढ़ी और कर्ज वसूली बेहतर हुई। नई म्यूचुअल फंड कंपनी ने 5,235 करोड़ रुपये का फंड जुटाया। प्रबंधन का कहना है कि आगे भी संतुलित वृद्धि जारी रहेगी। लेकिन सरकारी स्वास्थ्य और फसल बीमा में दावों का जोखिम बना हुआ है, जिससे मुनाफा प्रभावित हो सकता है।
Key Numbers
New business value growth supported by improved product mix and interest rate movement.
Strong AUM growth driven by diversified business model and customer acquisition.
Market share doubled from ~4% two years ago, driven by OEM tie-ups and long-term policies.
What Changed vs Last Quarter
Due to investments in manpower and rural expansion, combined ratio may temporarily exceed 100% before normalizing.
Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.
BFL continues to deliver on AUM growth, profitability, and asset quality targets as per its stated guidance.
Management expects absolute NBV to grow at a similar pace as historical 24% rolling 12-month growth, with margins stabilizing around 15%.
Expansion in distribution and geographies is expected to sustain motor growth in the medium term, though market dynamics may affect it.
After a tactical Q1 with higher ULIP share, PAR mix is expected to revert to December 2022 levels, with corrective actions already taken in July.
The Gujarat government health scheme may have higher loss ratios due to backlog claims, though 80% is reinsured.
BAGIC's expense ratio may rise as investments in manpower and rural branches continue, impacting near-term profitability.
Higher share of lower-margin products (ULIP, non-par) and investments in new channels may keep VNB margins below prior year levels.
Heavy rainfall in North India may lead to elevated motor and property claims, though management expects material impact to be assessed only in Q2 call.
Retail health loss ratios remain elevated due to fraud and claims inflation; management is investing in analytics but improvement may take time.
Management Guidance
BAGIC combined ratio to be slightly above 100% for next few quarters
Due to investments in manpower and rural expansion, combined ratio may temporarily exceed 100% before normalizing.
Management guidance marginsBALIC NBV growth expected to continue with product mix improvement
Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.
Management guidance growthBFL to maintain long-term financial guidance metrics
BFL continues to deliver on AUM growth, profitability, and asset quality targets as per its stated guidance.
Management guidance growthKey Risks
Government health business claims volatility
The Gujarat government health scheme may have higher loss ratios due to backlog claims, though 80% is reinsured.
medium · management_commentaryExpense ratio normalization pressure
BAGIC's expense ratio may rise as investments in manpower and rural branches continue, impacting near-term profitability.
medium · management_commentaryCompetition in crop insurance and government health
Analyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.
medium · analyst_questionBALIC VNB margin compression from product mix shift
Higher share of lower-margin products (ULIP, non-par) and investments in new channels may keep VNB margins below prior year levels.
medium · analyst_questionNotable Quotes
We have never done business in a desperate manner. We have always done business the way business should be done.
Our purpose is to create platform to carry out health transactions for customers. It's not about acquiring customers, it's all about enabling transactions digitally.
In insurance, you always do business on expectation of profit. If I definitely know that I'm going to lose money, I'll never do that business.
Frequently Asked Questions
What was Bajajfinsv's revenue in Q2 FY24?
Bajajfinsv reported revenue of ₹26,023 Cr in Q2 FY24, representing a +25% change compared to the same quarter last year.
What guidance did Bajajfinsv management give for FY25?
BAGIC combined ratio to be slightly above 100% for next few quarters: Due to investments in manpower and rural expansion, combined ratio may temporarily exceed 100% before normalizing. BALIC NBV growth expected to continue with product mix improvement: Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute. BFL to maintain long-term financial guidance metrics: BFL continues to deliver on AUM growth, profitability, and asset quality targets as per its stated guidance.
What are the key risks for Bajajfinsv in FY25?
Key risks include Government health business claims volatility — The Gujarat government health scheme may have higher loss ratios due to backlog claims, though 80% is reinsured.; Expense ratio normalization pressure — BAGIC's expense ratio may rise as investments in manpower and rural branches continue, impacting near-term profitability.; Competition in crop insurance and government health — Analyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.; BALIC VNB margin compression from product mix shift — Higher share of lower-margin products (ULIP, non-par) and investments in new channels may keep VNB margins below prior year levels..
Did Bajajfinsv meet its previous quarter's guidance?
Of 2 tracked promises, management 0 met, 0 close, 2 missed.
Where can I read the full Bajajfinsv Q2 FY24 concall transcript?
The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary with filing verification status shown on the financial stats.